222 related articles for article (PubMed ID: 9694962)
1. Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain.
Goldberg IE; Rossi GC; Letchworth SR; Mathis JP; Ryan-Moro J; Leventhal L; Su W; Emmel D; Bolan EA; Pasternak GW
J Pharmacol Exp Ther; 1998 Aug; 286(2):1007-13. PubMed ID: 9694962
[TBL] [Abstract][Full Text] [Related]
2. Possible involvement of dynorphin A-(1-17) release via mu1-opioid receptors in spinal antinociception by endomorphin-2.
Mizoguchi H; Watanabe H; Hayashi T; Sakurada W; Sawai T; Fujimura T; Sakurada T; Sakurada S
J Pharmacol Exp Ther; 2006 Apr; 317(1):362-8. PubMed ID: 16394196
[TBL] [Abstract][Full Text] [Related]
3. Differential involvement of mu-opioid receptor subtypes in endomorphin-1- and -2-induced antinociception.
Sakurada S; Zadina JE; Kastin AJ; Katsuyama S; Fujimura T; Murayama K; Yuki M; Ueda H; Sakurada T
Eur J Pharmacol; 1999 May; 372(1):25-30. PubMed ID: 10374711
[TBL] [Abstract][Full Text] [Related]
4. Differential involvement of mu(1)-opioid receptors in endomorphin- and beta-endorphin-induced G-protein activation in the mouse pons/medulla.
Mizoguchi H; Narita M; Wu H; Narita M; Suzuki T; Nagase H; Tseng LF
Neuroscience; 2000; 100(4):835-9. PubMed ID: 11036217
[TBL] [Abstract][Full Text] [Related]
5. Possible involvement of dynorphin A release via mu1-opioid receptor on supraspinal antinociception of endomorphin-2.
Sakurada S; Sawai T; Mizoguchi H; Watanabe H; Watanabe C; Yonezawa A; Morimoto M; Sato T; Komatsu T; Sakurada T
Peptides; 2008 Sep; 29(9):1554-60. PubMed ID: 18571771
[TBL] [Abstract][Full Text] [Related]
6. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF
Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238
[TBL] [Abstract][Full Text] [Related]
7. Different motivational effects induced by the endogenous mu-opioid receptor ligands endomorphin-1 and -2 in the mouse.
Narita M; Ozaki S; Ioka M; Mizoguchi H; Nagase H; Tseng LF; Suzuki T
Neuroscience; 2001; 105(1):213-8. PubMed ID: 11483313
[TBL] [Abstract][Full Text] [Related]
8. Activation and internalization of the mu-opioid receptor by the newly discovered endogenous agonists, endomorphin-1 and endomorphin-2.
McConalogue K; Grady EF; Minnis J; Balestra B; Tonini M; Brecha NC; Bunnett NW; Sternini C
Neuroscience; 1999 Mar; 90(3):1051-9. PubMed ID: 10218804
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of opioid receptor preference by [Dmt1]endomorphin-2-mediated antinociception in the mouse.
Jinsmaa Y; Fujita Y; Shiotani K; Miyazaki A; Li T; Tsuda Y; Okada Y; Ambo A; Sasaki Y; Bryant SD; Lazarus LH
Eur J Pharmacol; 2005 Feb; 509(1):37-42. PubMed ID: 15713427
[TBL] [Abstract][Full Text] [Related]
10. A novel non-opioid binding site for endomorphin-1.
Lengyel I; Toth F; Biyashev D; Szatmari I; Monory K; Tomboly C; Toth G; Benyhe S; Borsodi A
J Physiol Pharmacol; 2016 Aug; 67(4):605-616. PubMed ID: 27779481
[TBL] [Abstract][Full Text] [Related]
11. Potent in vivo antinociception and opioid receptor preference of the novel analogue [Dmt1]endomorphin-1.
Jinsmaa Y; Marczak E; Fujita Y; Shiotani K; Miyazaki A; Li T; Tsuda Y; Ambo A; Sasaki Y; Bryant SD; Okada Y; Lazarus LH
Pharmacol Biochem Behav; 2006 Jun; 84(2):252-8. PubMed ID: 16782179
[TBL] [Abstract][Full Text] [Related]
12. Lack of the involvement of mu1-opioid receptor subtype on motivational effects induced by the endogenous mu-opioid receptor ligands endomorphin-1 and -2 in the mouse.
Narita M; Ozaki S; Ioka M; Mizoguchi H; Nagase H; Tseng LF; Suzuki T
Neurosci Lett; 2001 Jul; 308(1):17-20. PubMed ID: 11445275
[TBL] [Abstract][Full Text] [Related]
13. Differential antagonism of endomorphin-1 and endomorphin-2 spinal antinociception by naloxonazine and 3-methoxynaltrexone.
Sakurada S; Hayashi T; Yuhki M; Fujimura T; Murayama K; Yonezawa A; Sakurada C; Takeshita M; Zadina JE; Kastin AJ; Sakurada T
Brain Res; 2000 Oct; 881(1):1-8. PubMed ID: 11033087
[TBL] [Abstract][Full Text] [Related]
14. In vitro binding and signaling profile of the novel mu opioid receptor agonist endomorphin 2 in rat brain membranes.
Spetea M; Monory K; Tömböly C; Tóth G; Tzavara E; Benyhe S; Hanoune J; Borsodi A
Biochem Biophys Res Commun; 1998 Sep; 250(3):720-5. PubMed ID: 9784412
[TBL] [Abstract][Full Text] [Related]
15. Endomorphin-1 and endomorphin-2 are partial agonists at the human mu-opioid receptor.
Hosohata K; Burkey TH; Alfaro-Lopez J; Varga E; Hruby VJ; Roeske WR; Yamamura HI
Eur J Pharmacol; 1998 Apr; 346(1):111-4. PubMed ID: 9617760
[TBL] [Abstract][Full Text] [Related]
16. Endomorphins fully activate a cloned human mu opioid receptor.
Gong J; Strong JA; Zhang S; Yue X; DeHaven RN; Daubert JD; Cassel JA; Yu G; Mansson E; Yu L
FEBS Lett; 1998 Nov; 439(1-2):152-6. PubMed ID: 9849897
[TBL] [Abstract][Full Text] [Related]
17. Itch-associated response and antinociception induced by intracisternal endomorphins in mice.
Yamaguchi T; Kitagawa K; Kuraishi Y
Jpn J Pharmacol; 1998 Nov; 78(3):337-43. PubMed ID: 9869268
[TBL] [Abstract][Full Text] [Related]
18. Novel highly potent mu-opioid receptor antagonist based on endomorphin-2 structure.
Fichna J; do-Rego JC; Janecki T; Staniszewska R; Poels J; Broeck JV; Costentin J; Schiller PW; Janecka A
Bioorg Med Chem Lett; 2008 Feb; 18(4):1350-3. PubMed ID: 18207400
[TBL] [Abstract][Full Text] [Related]
19. Nitrocinnamoyl and chlorocinnamoyl derivatives of dihydrocodeinone: in vivo and in vitro characterization of mu-selective agonist and antagonist activity.
McLaughlin JP; Hill KP; Jiang Q; Sebastian A; Archer S; Bidlack JM
J Pharmacol Exp Ther; 1999 Apr; 289(1):304-11. PubMed ID: 10087018
[TBL] [Abstract][Full Text] [Related]
20. Cross-tolerance between the different mu-opioid receptor agonists endomorphin-1, endomorphin-2 and morphine at the spinal level in the rat.
Labuz D; Przewlocki R; Przewlocka B
Neurosci Lett; 2002 Dec; 334(2):127-30. PubMed ID: 12435488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
